Bioantibody
Nanjing
About Bioantibody
Bioantibody is a high-tech biotechnology firm specializing in the research and development of antigens, antibodies, and downstream detection reagents for diagnosis and therapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $14.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2023)
- Website: bioantibody.net
- Phone: +86 025 58501357
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/bioantibody-119412 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.